XML 26 R10.htm IDEA: XBRL DOCUMENT v3.23.1
NOTE 4. CASH AND CASH EQUIVALENTS
3 Months Ended
Mar. 31, 2023
Cash and Cash Equivalents [Abstract]  
NOTE 4. CASH AND CASH EQUIVALENTS

NOTE 4. CASH AND CASH EQUIVALENTS

 

For purposes of the statements of cash flows, in accordance with ASC 230-10-20 the Company considers all highly liquid investments and short-term debt instruments with original maturities of three months or less to be cash equivalents. There was $1,436,346 in cash and cash equivalents as of March 31, 2023, and $479,129 as of December 31, 2022, respectively.